Trials / Completed
CompletedNCT01688323
Finding Predictors of Side Effects to Chemoradiation Treatment in Elderly Patients With Head and Neck Cancer
Identification of Predictors of Tolerance to Chemoradiotherapy in Elderly Patients With Head and Neck Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3 (actual)
- Sponsor
- UNC Lineberger Comprehensive Cancer Center · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
To look at what types of measures can be used to predict how an older person will tolerate chemoradiation treatment for head and neck cancer. This study uses surveys and a blood draw to look at the different measures.
Detailed description
Purpose: To identify baseline predictors of change in function over the course of treatment with chemoradiotherapy in patients with head and neck cancer. Participants: Patients 65 or older who have an appointment at the North Carolina Cancer Hospital (NCCH) or other participating sites, have planned chemoradiotherapy for head and neck cancer Procedures (methods): Consenting subjects will complete a Geriatric Assessment, Functional Assessment of Cancer Therapy - Head and Neck and give a blood sample for CBC and p16INK4a at the start of their chemoradiotherapy, at week four, at the end and 90 days post therapy. They will also complete a health behavior questionnaire at baseline.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Collect Blood and Survey Instruments | Each subject will be administered the appropriate surveys and blood draws over the course of the study. |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2014-07-01
- Completion
- 2016-05-01
- First posted
- 2012-09-19
- Last updated
- 2017-09-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01688323. Inclusion in this directory is not an endorsement.